Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00RJE
|
||||
| Former ID |
DIB009776
|
||||
| Drug Name |
Pancopride
|
||||
| Synonyms |
LAS-30451
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Nausea [ICD10:R11] | Phase 3 | [1] | ||
| Company |
Almirall Prodesfarma SA
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H24ClN3O2
|
||||
| Canonical SMILES |
c1(C(=O)NC2CN3CCC2CC3)c(cc(c(c1)Cl)N)OCC1CC1
|
||||
| CAS Number |
CAS 121650-80-4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-Hydroxytryptamine 3 receptor | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001751) | ||||
| REF 2 | Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis. Eur J Pharmacol. 1992 Nov 10;222(2-3):257-64. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.